Abstract
Cryptosporidium, a protozoan parasite of significant public health concern, is responsible for severe diarrheal disease, particularly in immunocompromised individuals and young children in resource-limited settings. Analysis of whole genome next generation sequencing (NGS) data is critical in improving our understanding of Cryptosporidium epidemiology, transmission, and diversity. However, effective analysis of NGS data in a public health context necessitates the development of robust, validated computational tools. We present Parapipe, an ISO-accreditable bioinformatic pipeline for high-throughput analysis of NGS data from Cryptosporidium and related taxa. Built using Nextflow DSL2 and containerised with Singularity, Parapipe is modular, portable, scalable, and designed for use by public health laboratories. Using both simulated and real Cryptosporidium datasets, we demonstrate the power of Parapipe’s genomic analysis for generating epidemiological insights. We highlight how whole genome analysis yields substantially greater phylogenetic resolution than conventional gp60 molecular typing in C. parvum. Uniquely, Parapipe facilitates the integration of mixed infection analysis and phylogenomic clustering with epidemiological metadata, representing a powerful tool in the investigation of complex transmission pathways and identification of outbreak sources. Parapipe significantly advances genomic surveillance of Cryptosporidium, offering a streamlined, reproducible analytical framework. By automating a complex workflow and delivering detailed genomic characterisation, Parapipe provides a valuable tool for public health agencies and researchers, supporting efforts to mitigate the global burden of cryptosporidiosis.
Full text
2,051 characters
· extracted from
oa-doi-fallback
· click to expand
Full text loading...
Abstract
Cryptosporidium, a protozoan parasite of significant public health concern, is responsible for severe diarrheal disease, particularly in immunocompromised individuals and young children in resource-limited settings. Analysis of whole genome next generation sequencing (NGS) data is critical in improving our understanding of Cryptosporidium epidemiology, transmission, and diversity. However, effective analysis of NGS data in a public health context necessitates the development of robust, validated computational tools. We present Parapipe, an ISO-accreditable bioinformatic pipeline for high-throughput analysis of NGS data from Cryptosporidium and related taxa. Built using Nextflow DSL2 and containerised with Singularity, Parapipe is modular, portable, scalable, and designed for use by public health laboratories.
Using both simulated and real Cryptosporidium datasets, we demonstrate the power of Parapipe’s genomic analysis for generating epidemiological insights. We highlight how whole genome analysis yields substantially greater phylogenetic resolution than conventional gp60 molecular typing in C. parvum. Uniquely, Parapipe facilitates the integration of mixed infection analysis and phylogenomic clustering with epidemiological metadata, representing a powerful tool in the investigation of complex transmission pathways and identification of outbreak sources.
Parapipe significantly advances genomic surveillance of Cryptosporidium, offering a streamlined, reproducible analytical framework. By automating a complex workflow and delivering detailed genomic characterisation, Parapipe provides a valuable tool for public health agencies and researchers, supporting efforts to mitigate the global burden of cryptosporidiosis.
- Received:
- Version Posted:
Funding
-
Health and Care Research Wales
(Award AF-24-10)
- Principal Award Recipient: Arthur V Morris
-
Wellcome Trust
(Award 215800/Z/19/Z)
- Principal Award Recipient: Tom Connor
-
CLIMB
(Award MR/T030062/1)
- Principal Award Recipient: Tom Connor
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.